TUFTS LINDA

CIK 00013886802 companiesMALVERN, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001388680

Recent Transactions

38 trades

Award
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2019-02-27+36,000→ 36,000 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
2018-10-22$0.12/sh+9,847→ 47,377 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series C-1 Preferred Stock
2018-10-22−991→ 0 total
Purchase
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22$5.00/sh+1,277→ 59,429 total
Purchase
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22$5.00/sh+6,041→ 281,096 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series B Preferred Stock
2018-10-22−710→ 0 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series C-1 Preferred Stock
2018-10-22−4,690→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22+275,055→ 275,055 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series B Preferred Stock
2018-10-22−7,053→ 0 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22$0.12/sh+7,053→ 347,420 total
Sale
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22$5.00/sh−170→ 347,250 total
Sale
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22$5.00/sh−18→ 34,968 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series B Preferred Stock
2018-10-22−3,359→ 0 total
Sale
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22$5.00/sh−81→ 165,395 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
2018-10-22$0.12/sh+991→ 4,770 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
2018-10-22$0.12/sh+4,690→ 22,565 total
Conversion
PhaseBio Pharmaceuticals Inc
Series AA Preferred Stock
2018-10-22−12,025→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Series D Preferred Stock
2018-10-22−63,688→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22+577,486→ 577,486 total
Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22+58,152→ 58,152 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22$0.12/sh+710→ 34,986 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22$0.12/sh+3,359→ 165,476 total
Sale
PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
2018-10-22$5.00/sh−237→ 47,140 total
Sale
PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
2018-10-22$5.00/sh−113→ 22,452 total
Conversion
PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
2018-10-22−47,140→ 0 total
Purchase
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22$5.00/sh+12,682→ 590,168 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series C-1 Preferred Stock
2018-10-22−9,847→ 0 total
Sale
PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
2018-10-22$5.00/sh−24→ 4,746 total
Conversion
PhaseBio Pharmaceuticals Inc
Series AA Preferred Stock
2018-10-22−119,408→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22−347,250→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22−34,968→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
2018-10-22−22,452→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Series D Preferred Stock
2018-10-22−6,413→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22−165,395→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
2018-10-22−4,746→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Series AA Preferred Stock
2018-10-22−56,874→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Series D Preferred Stock
2018-10-22−30,334→ 0 total
Award
U.S. Stem Cell, Inc.$USRM
Stock Option (right to buy)
2008-04-18+35,000→ 35,000 total

Companies

Recent Filings

Address

C/O PHASEBIO PHARMACEUTICALS, INC. 1 GREAT VALLEY PARKWAY, SUITE 30

MALVERN, PA, 19355

View on SEC.gov